The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSTN.L Regulatory News (HSTN)

  • There is currently no data for HSTN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on 2019 AGM voting outcome

3 Dec 2019 09:00

RNS Number : 4116V
Hansteen Holdings plc
03 December 2019
 

3 December 2019

HANSTEEN HOLDINGS PLC

("Hansteen", the "Company" or, the "Group")

 

 

Update on 2019 AGM voting outcome

 

 

In its 2019 AGM results announcement on 11 June 2019, the Company reported that all resolutions were passed, although there was a significant minority vote against the following resolutions:

 

·; Resolution 2 which related to the approval of the Annual Report on Remuneration. Total votes received in favour of this resolution were 73.13%; and

 

·; Resolution 7 which related to the re-election of Melvyn Egglenton, the Chairman of the Company, as a non-executive Director. Total votes received in favour of this resolution were 62.53%

 

In consultation with major shareholders, the Chairman and the Senior Independent Director identified that the reason behind the dissenting votes for Resolution 2 related to the final payment under the Founder Long Term Incentive Plan and Resolution 7 related to the absence of female representation on the Board:

 

Resolution 2

 

No further awards will be made under this Plan and therefore the reason for the votes against the Resolution no longer exists.

 

Resolution 7

 

When deciding whether to recruit a new non-executive Director to replace Margaret Young, who stepped down as a non-executive Director of the Company on 31 December 2018, the Board considered the significant reduction in the size of the Company from net assets of £924.2 million at 31 December 2016 to £470.1 million at 31 December 2018 and its expectations for the future. The reduction in net assets resulted from the disposal of property assets realising substantial profits followed by the return of capital to shareholders of £578.1 million in November 2017 and £144.5 million in May 2018.

 

Although there has been a significant reduction in the net assets, market capitalisation of the Company and complexity of the Group in the two years to 31 December 2018, the Company has maintained, and continues to maintain its strong control environment, high level of internal controls and robust processes. In light of the foregoing, the Board decided not to replace Margaret Young with another non-executive Director. This decision remains under review by the Board, and it will take into account any possible significant changes in the activities and/or size of the Company in the future and the Board would expect that any future additional appointments to the Board to reflect the desired expertise and background of potential candidates to complement the skills already on the Board while ensuring consideration of ethnicity and gender diversity, as part of the Company's recruitment process.

 

The Board will continue to engage with shareholders on the size, composition and diversity of the Board and will set out further details of any such consultation in the 2019 Annual Report and Accounts and associated documentation.

 

Enquiries:

Hansteen Holdings PLCMel Egglenton, Chairman

Morgan Jones, joint Chief ExecutiveIan Watson, joint Chief Executive

Tel: +44 (0) 20 7408 7000

www.hansteen.co.uk

Tavistock Jeremy Carey 

Tel: +44 (0) 20 7920 3150

jeremy.carey@tavistock.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUUVWRKBAURAA
Date   Source Headline
6th Feb 20209:30 amRNSScheme of Arrangement becomes effective
5th Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 20203:17 pmRNSForm 8.3 - Hansteen Holdings PLC
5th Feb 20202:25 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 20201:55 pmRNSHolding(s) in Company
5th Feb 20201:45 pmRNSForm 8.3 - [Hansteen Holdings plc]
5th Feb 202012:21 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 202012:11 pmRNSForm 8.5 (EPT/RI) - Hansteen Holdings Plc
5th Feb 202010:30 amRNSIssue of Equity and Director/PDMR Shareholding
5th Feb 202010:26 amRNSForm 8 (DD) - Hansteen Holdings PLC
5th Feb 202010:25 amRNSRule 2.9 Announcement
5th Feb 202010:25 amRNSForm 8 (DD) -Hansteen Holdings PLC
5th Feb 202010:25 amRNSForm 8 (DD) - Hansteen Holdings PLC
5th Feb 20207:30 amRNSSuspension of Listing & Trading in Hansteen Shares
4th Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 20202:28 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
4th Feb 20202:25 pmRNSCourt Sanction of the Scheme
4th Feb 20201:36 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 202012:41 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 202011:25 amRNSForm 8.3 - Hansteen Holdings PLC
4th Feb 202011:18 amRNSForm 8.3 - Hansteen Holdings Plc
4th Feb 202010:56 amRNSForm 8.3 - Hansteen Holdings Plc
4th Feb 20209:09 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
4th Feb 20209:05 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
4th Feb 20208:21 amRNSChange to Time of Court Hearing
3rd Feb 20203:34 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 20203:17 pmRNSForm 8.3 -Hansteen Holdings PLC
3rd Feb 20202:07 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
3rd Feb 20202:04 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202012:18 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202012:17 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202011:17 amRNSForm 8.3 - Hansteen Holdings Plc
3rd Feb 202010:45 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC - Replacement
3rd Feb 202010:04 amRNSForm 8.3 - Hansteen Holdings PLC
3rd Feb 20208:57 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
31st Jan 20205:30 pmRNSHansteen Holdings
31st Jan 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
31st Jan 20202:32 pmRNSRecommended Cash Acquisition
31st Jan 20201:45 pmRNSForm 8.3 - [Hansteen Holdings plc]
31st Jan 20201:43 pmRNSForm 8.3 - Hansteen Holdings plc
31st Jan 20201:28 pmRNSForm 8.3 - Hansteen Holdings Plc
31st Jan 202011:30 amRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20203:16 pmRNSForm 8.3 - Hansteen Holdings PLC
30th Jan 20201:33 pmRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20201:18 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
30th Jan 202012:18 pmRNSForm 8.3 - Hansteen Holdings Plc
30th Jan 202011:44 amRNSForm 8.3 - Hansteen Holdings plc
30th Jan 202011:21 amRNSForm 8.3 - Hansteen Holdings Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.